Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA—clinical utility, current limitations and future perspectives

Por de Melo Gagliato, Debora, Fontes Jardim, Denis L.
Publicado no Ann Transl Med (2018)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

Por Ikeda, Sadakatsu, Schwaederle, Maria, Mohindra, Mandakini, Fontes Jardim, Denis L., Kurzrock, Razelle
Publicado no J Hematol Oncol (2018)

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

Por Fontes Jardim, Denis L., Schwaederle, Maria, Wei, Caimiao, Lee, J. Jack, Hong, David S., Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Publicado no J Natl Cancer Inst (2015)

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

Por Tang, Chad, Fontes Jardim, Denis L., Falchook, Gerald S., Hess, Kenneth, Fu, Siqing, Wheler, Jennifer J., Zinner, Ralph G., Naing, Aung, Tsimberidou, Apostolia M., De Melo Galgiato, Debora, Westin, Shannon N., Meric-Bernstam, Funda, Kurzrock, Razelle, Hong, David S.
Publicado no Oncoscience (2013)

Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit

Por de Melo Gagliato, Debora, Fontes Jardim, Denis L., Falchook, Gerald, Tang, Chad, Zinner, Ralph, Wheler, Jennifer J., Janku, Filip, Subbiah, Vivek, Piha-Paul, Sarina A., Fu, Siqing, Hess, Kenneth, Roy-Chowdhuri, Sinchita, Moulder, Stacy, Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Hong, David S.
Publicado no Clin Breast Cancer (2014)